Shire Investor Relations / Board Of Directors

Discussion in 'Shire' started by anonymous, Aug 9, 2017 at 6:23 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Attn: Ian Clark /All Board Members
    Please implement a workforce reduction immediately in the OBU and NBU divisions. They continue to be a heavy burden on stockholders interests. We will be contacting specific hedge fund managers to move funds to a more stable and return oriented organization. Shareholders whose own fund managers exercise votes are well aware that you are breaching the corporate governance code.
     

  2. anonymous

    anonymous Guest

    Its time to start a Class Action Suit, if there isn't a 30% Sales Force reduction within the next six months.
     
  3. anonymous

    anonymous Guest

    What an idiot! Nice try.
     
  4. anonymous

    anonymous Guest

    Another one ?
     
  5. anonymous

    anonymous Guest

    Hope this isn't true.
     
  6. anonymous

    anonymous Guest

    Wheels are in motion for class action.
     
  7. anonymous

    anonymous Guest

    Oh and PLEASE fire Flemming too!
     
  8. anonymous

    anonymous Guest

    No, they need to rid the company of lazy bastards like you. Oh wait, We already did thats right slug.
     
  9. anonymous

    anonymous Guest

    Unlike those of us who got out it sounds like you have no other opportunities. Shire is tanking. The writing is on the wall. Flemming's bad decisions have run Shire into the ground. Flemming's follie tanked also. Him talking about selling off NBU in hopes of getting a bump in the Shire stock price. That's also ILLEGAL.
     
  10. anonymous

    anonymous Guest

    Fire those weak reps now, and outsource to all contract sales force.
     
  11. anonymous

    anonymous Guest

    Nice try. I am not the most sympathetic to this company by any measure but a major strategy is to get away from hedge fund investors (gambling on a take over or quick win) to biotech investors. Not sure the current share price is propping up that strategy though!
     
  12. anonymous

    anonymous Guest

    They already are.
     
  13. anonymous

    anonymous Guest

    Oooooh. No question the leadership is shaking in their boots over a threat on CP. But you've nicely displayed the sort of posts executives ignore but have the effect of minimizing any useful posts on CP.
     
  14. anonymous

    anonymous Guest

    This wouldn't surprise me, Neuro is the largest expense the company has. OBU is the biggest waste of $. This explains the deviance with the Mydayis bonus plan, FO did you really think the sales force wouldn't notice you tried to hoodwink them. They are trying make make the sales force think they will make money hoping they kick butt in the field.
    They need to ramp up Mydayis and keep Vyvanse growing so they can unload the NBU and get $8-11 billion for it soon before the window closes. FO and PS bit off more than Shire could chew and now their chickens have come home to roost and I wouldn't be surprised if they are on the chopping block. I am sure the Board is pissed that the stock is in the 150's- down from the high of over $267 a couple years ago.
     
  15. anonymous

    anonymous Guest

    Almost as mad at you Baxalta troll.
     
  16. anonymous

    anonymous Guest

    Calm down. Baxalta has nothing to do with this.
     
  17. anonymous

    anonymous Guest

    Stock is surging. Culture is the best. Large bonus coming and Life is good.
     
  18. anonymous

    anonymous Guest

    Should crack $200 by Q118. Bullish stock with a CEO that can drive returns to the moon.
     
  19. anonymous

    anonymous Guest

    Time to have redundancies and trim the dead wood around here. FO needs to take action and fire non- contracted salespeople now. Also toss NBU OBU.
     
  20. anonymous

    anonymous Guest


    Most importantly resign so the leadership team can be replaced